bpc-157 fda approved Approval Status: Is It for Human Use? EVEXIAS Life Sciences filing lawsuit
Description
Each 3ml vial contains approximately 5mg BPC-157 and 10mg TB-500, pre-mixed at an optimal ratio by a licensed compounding pharmacy
Both promote angiogenesis through different pathways that compound rather than compete
Y26:IkpVop;fuh56aqxQn+GBuK;hu!
Combines BPC-157 and TB-500 into a single powerful recovery protocol
